Correlation of progression-free and post-progression survival with overall survival in phase III trials of first-line chemotherapy for advanced epithelial ovarian cancer.

Shimokawa, M; Ohki, M; Kaku, T

Shimokawa, M; Ohki, M; Kaku, T.

Eur J Gynaecol Oncol ; 36(4): 370-5, 2015.

Article in En | MEDLINE | ID: mdl-26390685

Subject(s)

Neoplasms, Glandular and Epithelial/mortality; Ovarian Neoplasms/mortality; Carcinoma, Ovarian Epithelial; Clinical Trials, Phase III as Topic; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial/drug therapy; Ovarian Neoplasms/drug therapy

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Ovarian Neoplasms / Neoplasms, Glandular and Epithelial Limits: Female / Humans / Middle aged Language: En Year: 2015 Type: Article

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Ovarian Neoplasms / Neoplasms, Glandular and Epithelial Limits: Female / Humans / Middle aged Language: En Year: 2015 Type: Article